- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 1044-1058 of
1,371 results
2114 Exhibit: JSN 2114 Williams et al, ¿¿¿Objective Responses to Ketoconazole The...
Document
IPR2016-01582, No. 2114-191 Exhibit - JSN 2114 Williams et al, ¿¿¿Objective Responses to Ketoconazole Therapy in Patients with Relapsed Progressive Prostatic Cancer,¿¿¿ British Journal of Uro...
|
|
Cite Document
2040 Exhibit: JSN 2040 Declaration of Richard Auchus, MD, PhD
Document
IPR2016-01582, No. 2040-119 Exhibit - JSN 2040 Declaration of Richard Auchus, MD, PhD (P.T.A.B. Mar. 17, 2017)
|
|
Cite Document
1015 Exhibit: Oh 2002
Document
IPR2016-01582, No. 1015-14 Exhibit - Oh 2002 (P.T.A.B. Aug. 10, 2016)
|
|
Cite Document
1059 Exhibit: Patent Valuation Improving Decision Making through Analysis 2012
Document
IPR2016-01582, No. 1059-58 Exhibit - Patent Valuation Improving Decision Making through Analysis 2012 (P.T.A.B. Aug. 10, 2016)
|
|
Cite Document
2057 Exhibit: JSN 2057 Bubley et al, ¿¿¿Eligibility and Response Guidelines for Phas...
Document
IPR2016-01582, No. 2057-136 Exhibit - JSN 2057 Bubley et al, ¿¿¿Eligibility and Response Guidelines for Phase II Clinical Trials in Androgen Independent Prostate Cancer Recommendations Fro...
|
|
Cite Document
2134 Exhibit: JSN 2134 ZYTIGA Market Share data
Document
IPR2016-01582, No. 2134-204 Exhibit - JSN 2134 ZYTIGA Market Share data (P.T.A.B. Mar. 17, 2017)
|
|
Cite Document
2132 Exhibit: JSN 2132 Order Granting Janssen¿¿¿s Motion to Set a Hearing and Co...
Document
IPR2016-01582, No. 2132-202 Exhibit - JSN 2132 Order Granting Janssen¿¿¿s Motion to Set a Hearing and Correct Inventorship of the ¿¿¿438 Patent (P.T.A.B. Mar. 17, 2017)
|
|
Cite Document
1079 Exhibit: Attard 2008
Document
IPR2016-01582, No. 1079-77 Exhibit - Attard 2008 (P.T.A.B. Aug. 10, 2016)
|
|
Cite Document
2083 Exhibit: JSN 2083 Novacea Form 8 K at 102
Document
IPR2016-01582, No. 2083-162 Exhibit - JSN 2083 Novacea Form 8 K at 102 (P.T.A.B. Mar. 17, 2017)
|
|
Cite Document
1023 Exhibit: Ryan 2013
Document
IPR2016-01582, No. 1023-22 Exhibit - Ryan 2013 (P.T.A.B. Aug. 10, 2016)
|
|
Cite Document
2048 Exhibit: JSN 2048 Altman et al, ¿¿¿The Revised CONSORT Statement for Repo...
Document
IPR2016-01582, No. 2048-127 Exhibit - JSN 2048 Altman et al, ¿¿¿The Revised CONSORT Statement for Reporting Randomized Trials Explanation and Elaboration,¿¿¿ Ann Intern Med, 134663 69...
|
|
Cite Document
2022 Exhibit: JSN 2022 Debruyne and Witjes, ¿¿¿Ketoconazole High Dose HD In The...
Document
IPR2016-01582, No. 2022-103 Exhibit - JSN 2022 Debruyne and Witjes, ¿¿¿Ketoconazole High Dose HD In The Management Of Metastatic Prostatic Carcinoma,¿¿¿ The Journal of Urology, 1354, pt...
|
|
Cite Document
1049 Exhibit: American Cancer Society
Document
IPR2016-01582, No. 1049-48 Exhibit - American Cancer Society (P.T.A.B. Aug. 10, 2016)
|
|
Cite Document
1066 Exhibit: Medivation Press Release Sept 10, 2014
Document
IPR2016-01582, No. 1066-65 Exhibit - Medivation Press Release Sept 10, 2014 (P.T.A.B. Aug. 10, 2016)
|
|
Cite Document
1087 Exhibit: BTG Licenses New Prostate Cancer Drug to Cougar Biotechnology,
Document
IPR2016-01582, No. 1087-243 Exhibit - BTG Licenses New Prostate Cancer Drug to Cougar Biotechnology, (P.T.A.B. Apr. 19, 2017)
|
|
Cite Document
